Neil Kumar Insider Profile
4 Followers
Neil Kumar, Director at BridgeBio Oncology Therapeutics, holds ― shares in BridgeBio Oncology Therapeutics (Ticker: BBOT), holds 5.11M shares in BridgeBio Pharma (Ticker: BBIO), holds 24.58M shares in Eidos Therapeutics (Ticker: EIDX). Most recently, Neil Kumar ― shares of BridgeBio Oncology Therapeutics on ― for an estimated value of ―.
Neil Kumar BridgeBio Oncology Therapeutics (BBOT)Director
BridgeBio Oncology Therapeutics (BBOT)
Director
Ranked #84,395 out of 108,575 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
-23.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Neil Kumar holds in companies
Most Profitable Insider Trade
Stock:
Eidos Therapeutics
(EIDX)
(EIDX)
Rating:Informative Buy
Date:May 29, 2019 - May 29, 2020
Return:+57.20%
The most profitable trade made by Neil Kumar
Neil Kumar's Trading History
BridgeBio Oncology Therapeutics
―
Director
―
―
Eidos Therapeutics
Jul 08, 2019
―
Informative Buy
26.38M
$3.00B
BridgeBio Pharma
Aug 18, 2026
CEO, Director
Uninformative Buy
2.79M
$408.43M
Maze Therapeutics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Neil Kumar's performance on stock
You May Also Like
Neil Kumar insider profile FAQ
What is the percentage of profitable transactions made by Neil Kumar?
The percentage of profitable transactions made by Neil Kumar is 75%.
What is the average return per transaction made by Neil Kumar?
The average return per transaction made by Neil Kumar is -23.20%.
What stocks does Neil Kumar hold?
Neil Kumar holds: BBOT, EIDX, BBIO, MAZE stocks.
What was Neil Kumar’s latest transaction?
Neil Kumar latest transaction was an Uninformative Buy of ―.
What was Neil Kumar's most profitable transaction?
Neil Kumar’s most profitable transaction was an Informative Buy of EIDX stock on May 29, 2019. The return on the trade was 57.20%.
What is Neil Kumar's role in BridgeBio Oncology Therapeutics?
Neil Kumar's role in BridgeBio Oncology Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.